RNA Manufacturing Resources
-
mRNA/saRNA Manufacturing RNA Analytics And Testing
5/24/2023
Venkata Indurthi, Ph.D., shares his knowledge and experience with manufacturing RNA, including key downstream considerations for RNA characterization and purity and how optimization can result in more efficient dosing.
-
Where Can Novel Non-Viral Polymeric Delivery Agents Take Us?
1/18/2023
Explore ongoing work to harness different types of HDR templates in order to build cutting-edge systems with the potential to enable point-of-care cell and gene therapy manufacture.
-
mRNA Product Purification Process Strategies
2/15/2023
Impurities from IVT can induce undesired immune responses and negatively impact translation efficiency. Explore the pros and cons of each option for mRNA purification.
-
Downstream Process Development For Efficient Purification Of Adenovirus
9/10/2018
Here, we describe the development of two effective downstream processes for purification of adenovirus from cell culture harvest.
-
Understanding The Hidden Value Of Quality
6/26/2023
Costs of poor quality (COPQ) cannot be overstated. Review the statistics that prove how costly it can be to avoid resolving quality issues in your processes and supply chain.
-
Separation Of cfDNA With An NGS Kit On Fragment Analyzer Systems
3/19/2026
Learn how precise sizing methods reveal nucleosome patterns in cfDNA and help distinguish true signal from extraction‑related artifacts for more reliable genomic analysis.
-
The Chilled Future Of mRNA Filling And Freezing
4/17/2023
Manufacturers at biotech and biopharma companies need help keeping up with continuously advancing novel treatments. Technologies that provide control over the freeze-thaw process offer solutions.
-
Optimization Of Transient Transfection Of MSCs With Plasmid DNA Or mRNA
11/1/2022
Read through the results of our efforts to produce an optimal protocol for the transient transfection of hMSCs with pDNA or mRNA using non-viral means.
-
The Future Is Now: CGT Innovation, Challenges, And Perspectives
7/19/2023
As CGTs advance toward clinical trials, developers face a number of challenges such as navigating a shifting regulatory landscape and employing beneficial manufacturing processes.
-
Key Insights Into Overcoming mRNA Process Challenges
9/8/2021
Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.